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SUMMARY
Histamine H1 receptors mediate activation of phospholipase C,
with subsequent increases in cytosolic Ca2 concentration
([Ca21), and H2 receptors mediate accumulation of cAMP. HL-
60 promyelocytes possess H2 receptors, but it is not known
whether these cells also possess H1 receptors. We studied the
effects of histamine on [Ca2] and the functional importance of
histamine receptors in HL-60 promyelocytes. In these cells,
histamine and dimaprit increased [Ca2] with EC50 values of 15
tM and 30 ffM, respectively. Diphenhydramine inhibited the effect
of histamine (1 00 M) on [Ca21 up to 40%, with an IC50 of 100
nM. Famotidine and cimetidine diminished the effect of histamine
(100 ffM) up to 75#{176}Io,with IC50 values of 85 n and 300 n,
respectively. Diphenhydramine plus famotidine abolished hista-
mine-induced rises in [Ca2]. Impromidine, with an lC of 100
nM, abolished the effect of histamine (100 M) on [Ca2],. Di-
phenhydramine, famotidine, cimetidine, and impromidine showed
marked noncompetitive antagonism with histamine. Histamine-
induced increases in [Ca21, were largely due to influx of Ca2
from the extracellular space. Ca2 influx was inhibited by 1-/3-
[3-(4-methoxyphenyl)propoxyl]-4-methoxyphenethyl-1 H-imid-
azole hydrochloride (SK&F 96365). Histamine activated phos-
pholipase C. Histamine induced expression of formyl peptide
receptors, which effect was abolished by famotidine. In U-937
promonocytes and in the human erythroleukemia cell lines HEL
and K-562, histamine did not induce rises in [Ca21. Our data
suggest the following. (i) In HL-60 promyelocytes, histamine
increases [Ca21 predominantly via H2 receptors and to a lesser
extent via H1 receptors. (ii) The agonist/antagonist profile of the
H2 receptor-mediated increases in [Ca2] differs markedly from
that for cAMP accumulation, suggesting the involvement of
different H2 receptor subtypes. (iii) In HL-60 promyelocytes,
histamine activates nonselective cation channels and induces
functional differentiation via H2 receptors.
HL-60 promyelocytes possess histamine H2 receptors, which
mediate activation of adenylyl cyclase, with subsequent in-
creases in cAMP (1, 2). Dibutyryl-cAMP-differentiated HL-60
cells possess H1 and H2 receptors; the former receptors mediate
activation of phospholipase C and of nonselective cation chan-
nels, resulting in an increase in [Ca2] (3, 4). Stimulation by
dimaprit of H2 receptors in HL-60 promyelocytes results in
differentiation towards neutrophils (2). Histamine induces neu-
trophilic differentiation of HL-60 cells as well, but it is not
known whether this occurs via H, or H2 receptors (5). Interest-
ingly, activation of H1 receptors may result in potentiation of
H2 receptor-mediated cAMP accumulation (6). HL-60 promye-
locytes also possess ATP receptors, which mediate activation
ofphospholipase C and increases in [Ca2]1 (7-10). Intriguingly,
ATP induces functional differentiation of HL-60 cells, as as-
sessed by increased expression of formyl peptide receptors (9).
This work was supported by grants from the Deutsche Forschungsgemein-
schaft and the Fonda der Chemischen Industrie.
The findings described above prompted us to study the effects
of histamine on [Ca2] and the functional importance of his-
tamine receptors in HL-60 promyelocytes. We report here that
histamine increases [Ca2}, in HL-60 promyelocytes predomi-
nantly via H2 receptors. We suggest that H2 receptor-mediated
rises in [Ca2]1 and cAMP involve different H2 receptor sub-
types, and we show that histamine, via H2 receptors, induces
functional differentiation of HL-60 promyelocytes.
Experimental Procedures
Materials. (R)-a-Methylhistamine was a gift from Dr. W. Schunack
(Institut f#{252}rPharmazie, Freie Universitdt Berlin, Berlin, Germany).
Pertussis toxin was donated by Dr. M. Yajima (Kaken Pharmaceutical,
Otsu, Japan). SK&F 96365 was a gift from Dr. D. Arndts (Boehringer
Ingelheim, Ingelheim, Germany). myo[2H]Inositol (10-20 Ci/mmol)
was purchased from Amersham-Buchier (Braunschweig, Germany).
Arpromidine, dimaprit, and impromidine were synthesized as described
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(11-13). U-937, HEL, and K-562 cells were purchased from the Amer-
ican Type Culture Collection (Rockville, MD). Fetal calf serum was
obtained from GIBCO (Berlin, Germany). Sources of other materials
have been described elsewhere (3, 4, 10, 14, 15).
Cell culture. HL-60 promyelocytes were grown in suspension cul-
ture in RPMI 1640 medium supplemented with 10% (v/v) horse serum,
1% (v/v) nonessential amino acids, 2 mM L-glutamine, 50 units/ml
penicillin, and 50 ig/ml streptomycin, in a humidified atmosphere with
7% CO2 at 37’ . For experiments with pertussis toxin-treated cells, HL-
60 promyelocytes were treated with pertussis toxin (1 g/ml) or its
vehicle (control) for 24 hr. Thereafter, cells were harvested and exper-
iments were performed. HL-60 promyelocytes were differentiated to-
wards neutrophils upon exposure for 96 hr to histamine (100 M) (5).
U-937, HEL, and K-562 cells were grown in suspension culture in
RPM! 1640 medium supplemented with 10% (v/v) fetal calfserum, 1%
(v/v) nonessential amino acids, 2 mM L-glutamine, 50 units/mI peni-
cillin, and 50 ig/ml streptomycin, in a humidified atmosphere with 5%
CO2 at 37’. Cell viability was assessed by trypan blue dye exclusion.
Measurement of [Ca211. [Ca2], was determined with the dye fura-
2/AM, as described (10), with modifications. Cells were suspended at
1 x iO cells/mi in a buffer consisting of (in mM) 138 NaCI, 6 KC1, 1
MgSO4, 1 Na2HPO4, 5 NaHCO,, 5.5 glucose, and 20 HEPES-NaOH,
pH 7.4, supplemented with 0.1% (w/v) bovine serum albumin. Fura-2/
AM was added at a concentration of 4 sM, and cells were incubated for
10 mm at 3T. Thereafter, cells were diluted with the aforementioned
buffer to a concentration of 5 x 106 cells/ml and were incubated for 45
mm at 3T . Subsequently, cells were diluted with the aforementioned
buffer to a final concentration of0.5 X 106 cells/ml and were centrifuged
at 250 x g for 10 mm at 20’. Cells were suspended at 1.0 x 106 cells/
ml in the aforementioned buffer and were kept at 20 until measure-
ment of [Ca2],. HL-60 promyelocytes were used for up to 4 hr after
loading with fura-2/AM (7). Experiments with the other myeloid cell
types were completed within 1-1.5 hr. Within these times, basal
[Ca2], in myeloid cells did not rise by more than 20-40 nM, and the
responsiveness to any of the stimuli studied did not change signifi-
cantly. Basal [Ca2] in freshly loaded HL-60 promyelocytes was 103 ±
8 nM (mean ± standard deviation; 20 different preparations of HL-60
cells) and did not differ significantly in control and pertussis toxin-
treated cells (data not shown). Myeloid cells (1.0 x 106 cells) were
suspended in 2 ml of the aforementioned buffer, using acryl fluores-
cence cuvettes (Sarstedt, N#{252}mbrecht, Germany). Fluorescence was
determined at 37’, with constant stirring of the cells at 1 x iO rpm,
using a Ratio II spectrofluorometer (Aminco, Silver Spring, MD). Cells
were incubated for 3 mm at 37’ , in the absence or presence of various
substances (e.g., histamine receptor antagonists), before the addition
of stimuli; basal fluorescence (basal [Ca2]) was measured for 1 mm.
The excitation and emission wavelengths were 340 and 500 nm, re-
spectively. Basal [Ca2]1 values and peak [Ca2], values stimulated by
agonists were calculated according to eq. 6 given in Ref. 16. Basal
[Ca2i1 values were subtracted from the corresponding peak [Ca2J,
values, to calculate the increase in [Ca2]1 induced by a given agonist.
Unless stated otherwise, all experiments were performed in the pres-
ence of extracellular Ca2 ( 1 mM CaCl2 added to the buffer 3 mm before
stimuli). Quantitative comparison of peak [Ca2j1 values in myeloid
cells (e.g., comparison of control cells versus antagonist- or pertussis
toxin-treated cells) is based on the responses to stimuli in different
aliquots of a given preparation of loaded cells. For the generation of
complex concentration-response curves (see Figs. 1-4), the following
procedure was adopted. Immediately after an aliquot of cells was
challenged with a stimulus, the next aliquot of cells was equilibrated to
37* in a water bath. After 2 mm (ICa2] values in the challenged aliquot
of cells had already declined), the fresh aliquot was placed into the
fluorometer, to assess basal [Ca2],. By this procedure, up to 80 aliquots
of cells could be analyzed within 4 hr. Due to the stability in the
responsiveness of HL-60 promyelocytes, agonist and/or antagonist
concentrations were not randomized, but they were varied in a system-
atic manner by starting with agonists and/or antagonists at low con-
centrations.
Labeling of phosphoinositides in HL-60 promyelocytes and
measurement of inositol phosphate formation. For labeling of
phosphoinositides in HL-60 cells, cells were grown for 48 hr in inositol-
free RPM! 1640 medium supplemented with 10% (v/v) horse serum,
1% (v/v) nonessential amino acids, 2 mM L-glutamine, 50 units/ml
penicillin, 50 tg/ml streptomycin, and 2-5 .tCi/ml myo-[2-3H]inositol,
in a humidified atmosphere with 7% CO2 at 37’. Prelabeled cells were
centrifuged at 250 x g for 10 mm at 20. Cells were suspended in the
buffer used for the determination of [Ca2]. Cells were recentrifuged
and suspended in buffer. After another centrifugation of the cells, they
were suspended at 1 x iO cells/ml in buffer. Reactions were performed
at 37’ in buffer supplemented with 1 mM CaCl2, in a final volume of
200 MI Reactions were initiated by addition of 100 zl of cells to 100 zl
of buffer containing solvent (control) or the stimulus at the desired
concentration. Assays did not contain LiCl. Reactions were stopped
after 30 sec by addition of 400 Ml of a solution consisting of CHCI3,
CH3OH, and concentrated HC1 (100:200:1, v/v/v). Thereafter, 125 
of CHCI3 and 25 l of H20 were added to the reaction mixtures. After
centrifugation for phase separation, 350  of the aqueous phase were
loaded on Dowex 1 x 8 columns (0.8 x 2 cm). Inositol phosphates were
eluted as described (17). The eluates (8 ml) were mixed with 12 ml of
Flow-szint IV scintillation fluid (Camberra Packard, Frankfurt/Main,
Germany), and radioactivity was determined by scintillation counting.
Calculations. EC and  values were obtained by graphically
analyzing the concentration-response curves shown in Figs. 1-4.
Results
Histamine and dimaprit induce increases in [Ca211 in
HL-60 promyelocytes. Histamine increased [Ca2] with an
EC50 of 15 M and a maximum at 0.3-1.0 mM (Fig. 1). Dimapnit
increased [Ca2], with an EC50 of 30 M and a maximum at 100
tM. The effectiveness of dimaprit (1 mM) to increase [Ca2]
amounted to 20% of that of histamine (1 mM). Pertussis toxin
ADP-nibosylates heterotnimenic regulatory guanine nucleotide-
binding proteins of the G1 family and thereby prevents cell
activation by various receptor agonists (4, 7, 10). In HL-60
pnomyelocytes, however, pertussis toxin treatment did not af-
fect the histamine- and dimapnit-induced rises in [Ca2] (see
Fig. 1).
Betahistine (a weak partial H, agonist) (6, 18), arpromidine
(a potent H2 agonist and H, antagonist) (11), impromidine (a
potent H2 agonist and H3 antagonist and weak H, antagonist)
(6, 18), and (R)-s-methylhistamine (a potent H3 agonist) (18,
19), at concentrations up to 100 j.M, did not induce rises in
[Ca2]1 in HL-60 promyelocytes (data not shown). Diphenhy-
dramine (an H, antagonist) (6, 18) and cimetidine and famo-
tidine (H2 antagonists) (18, 20), at up to 100 zM each, did not
affect basal [Ca2] or induce a rise in [Ca2]1 in HL-60 pro-
myelocytes (data not shown). Diphenhydramine, cimetidine,
famotidine, and impromidine, at up to 100 tM each, showed no
inhibitory effect on rises in [Ca2] induced by ATP (10 tiM)
(data not shown). The cell-permeant cAMP analogue dibutyryl-
cAMP (1 mM) did not induce rises in [Ca2] (data not shown).
H, and H2 antagonists and impromidine inhibit hista-
mine-induced rises in [Ca2’], in HL-6O promyelocytes.
The effects of diphenhydramine, cimetidine, famotidine, and
impromidine on the rises in [Ca2]1 induced by histamine (100
tM) were studied (Fig. 2). Diphenhydramine reversed stimula-
tion caused by histamine with an IC50 of 100 nM and a plateau
at 10-100 tM. Diphenhydramine (100 sM) reduced the stimu-
latory effect of histamine by approximately 40%. Cimetidine
and famotidine inhibited the effects of histamine with IC50
values of 300 nM and 85 nM, respectively, and both substances
at 100 sM diminished the histamine-induced rises in [Ca2]1 by
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about 75%. Impromidine antagonized the effects of histamine
with an IC50 of 100 nM, and inhibition was complete at 100 tM.
Famotidine (100 zM) abolished the stimulatory effect of dima-
prit (100 M) on [Ca2]1, whereas diphenhydramine (100 zM)
was ineffective (data not shown).
Fig. 3 shows concentration-response curves for histamine in
the absence or presence of diphenhydramine, famotidine, or a
combination of both antagonists at a high concentration (100
zM each). Diphenhydramine reduced the effectiveness of his-
tamine to increase [Ca2}, without changing its EC50. Famoti-
dine increased the EC50 for histamine by about 4-fold and
greatly reduced its effectiveness. Marked reductions in the
effectiveness of histamine (1 aM to 3 mM) to induce rises in
[Ca2} were also observed with famotidine at 100 nM, 1 sM,
and 10 zM (data not shown). The combination of diphenhydra-
mine plus famotidine (100 sM each) abolished the stimulatory
effects of histamine, at concentrations as high as 3 mM, on
[Ca2}1 (see Fig. 3).
The effects of impromidine and cimetidine, at increasing
fixed concentrations, on the concentration-response curve for
histamine were assessed (Fig. 4). Impromidine, in a concentra-
tion-dependent manner, decreased the effectiveness of hista-
mine to induce rises in [Ca2}. Impromidine at up to 1 M did
not substantially increase the EC50 for histamine. Impromidine
at 10 and 100 sM increased the EC50 for histamine by about 6-
and 30-fold, respectively. Cimetidine greatly depressed the con-
centration-response curve for histamine and slightly increased
its EC50.
Histamine activates nonselective cation channels in
HL-60 promyelocytes. Histamine induced transient in-
creases in [Ca2]1 (Fig. 5). Histamine-induced rises in [Ca2]1
depended largely on Ca2 influx, inasmuch as in the absence of
extracellular Ca2 the magnitude and duration of rises in
[Ca’] were greatly reduced. SK&F 96365 is a blocker of
nonselective cation channels and inhibits receptor agonist-
induced Ca2 influx in neutrophils and in dibutyryl-cAMP-
differentiated HL-60 cells (4, 21). SK&F 96365 (10 taM) sub-
stantially diminished histamine-induced Ca2 influx in HL-60
promyelocytes (see Fig. 5). SK&F 96365 (30 M) abolished
histamine-induced Ca2 influx without affecting Ca2 mobili-
zation from intracellular stores (data not shown). Thus, hista-
mine-induced rises in [Ca2]1 in HL-60 promyelocytes were
largely due to Ca2 influx through nonselective cation channels.
Histamine activates phosphoinositide degradation in
HL-60 promyelocytes. A small part ofthe histamine-induced
rise in [Ca2]1 in HL-60 promyelocytes was due to mobilization
of Ca2 from intracellular stores (see Fig. 5). Because Ca2
mobilization is preceeded by formation of InsP3 (7), the effects
of histamine on phosphoinositide degradation were studied. In
agreement with the small effect of histamine on Ca2 mobili-
zation, histamine slightly stimulated formation of InsP:, (Ta-
ble 1).
Effects of ATP and histamine on [Ca21, in various
human myeloid cell types. ATP induces increases in
[Ca2]1 in HL-60 promyelocytes and U-937 promonocytes and
induces differentiation of these cells (7-9). Therefore, we stud-
ied the effects of histamine and ATP on fCa2] in various
H2 Receptors in HL-60 Promyelocytes 237
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Fig. 1. Concentration-response curves for histamine- and dimaprit-in-
duced rises in [Ca21 in HL-60 promyelocytes and lack of effect of
pertussis toxin. HL-60 cells were treated with pertussis toxin (1 tg/ml)
or its vehicle (control) for 24 hr. Thereafter, cells were harvested and
loaded with fura-2/AM, and the increases in [Ca21, induced by histamine
or dimaprit were assessed. U, Control cells stimulated with histamine;
., pertussis toxin-treated cells stimulated with histamine; A, control cells
stimulated with dimaprit; V, pertussis toxin-treated cells stimulated with
dimaprit. 0, Substances at the designated concentrations did not in-
crease [Ca2]. Data shown are the means ± standard deviations of four
experiments performed with different preparations of HL-60 cells.
antagonist (-log M)
Fig. 2. Concentration-response curves for the inhibitory effects of di-
phenhydramine, cimetidine, famotidine, and impromidine on histamine-
induced rises in [Ca2}, in HL-60 promyelocytes. HL-60 cells were har-
vested and loaded with fura-2/AM, and the increases in [Ca2j induced
by histamine at a fixed concentration (100 MM), in the presence of
antagonists at various concentrations, were assessed. In the absence
of antagonists, histamine (1 00 M) increased [Ca2J by 194 ± 1 4 n
(mean ± standard deviation of five experiments performed with different
preparations of HL-60 cells). Antagonists were added to cells 3 mm
before histamine. #{149},Diphenhydrammne; A, cimetidine; U, famotidine;#{149},
impromidine. 0, Antagonists at the designated concentrations did not
show an inhibitory effect on histamine-induced rises in [Ca2]. Data
shown are the means of five experiments performed with different
preparations of HL-60 cells. The standard deviation values of the data
generally amounted to <1 0% of the means.
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histamine did not show stimulatory effects on [Ca2]1 in U-937
promonocytes and in HEL cells, and it also did not induce rises
in [Ca2], in K-562 cells.
Histamine induces functional differentiation of HL-
60 cells, which is inhibited by famotidine. In order to
assess the functional importance of histamine receptors in HL-
60 promyelocytes, the effects of histamine, famotidine, and
diphenhydramine on differentiation were studied. Differentia-
tion of HL-60 promyelocytes results in increased expression of
formyl peptide receptors, which process is readily monitored by
the increased effectiveness of fMet-Leu-Phe to induce rises in
[Ca2], (9, 10, 15). The responsiveness to fMet-Leu-Phe of HL-
60 cells treated for 96 hr with histamine (100 pM) was substan-
tially greater than that of HL-60 promyelocytes (Table 3).
Famotidine abolished the effect of histamine, whereas diphen-
hydramine showed no effect. Famotidine and diphenhydramine
per se did not induce changes in the effectiveness of fMet-Leu-
Phe to induce rises in [Ca2], in HL-60 cells. In order to evaluate
the contribution of Ca2 influx to histamine-induced differen-
tiation, SK&F 96365 (30 MM) was added to the culture medium.
SK&F 96365 was cytotoxic, i.e., after 48 hr >95% of the cells
had lost viability (data not shown). Similarily, chelation of Ca2
by EGTA in the culture medium was cytotoxic (data not
7 6 5 4 3 2 shown).
0- ..-.-.-.-.
112 receptors mediate a large portion of histamine-
induced rises in [Ca211 in HL-60 promyelocytes. In HL-
60 promyelocytes, histamine induces cAMP accumulation via
H2 receptors (1). Additionally, histamine activates phospholi-
pase C-catalyzed InsP, formation, Ca2 mobilization from in-
tracellular stores, and Ca2 influx through nonselective cation
channels in these cells (see Fig. 5 and Table 1). It is unlikely
that histamine-induced rises in [Ca2] in HL-60 promyelocytes
were due to histamine-induced rises in cAMP, inasmuch as a
cell-permeant analogue of cAMP did not increase [Ca2]. Sur-
prisingly, the effects of histamine on [Ca2]1 in HL-60 promye-
locytes are mediated largely via H2 receptors and not via H,
receptors, as suggested by several findings. First, H2 antagonists
(cimetidine and famotidine) partially inhibited the stimulatory
effects of histamine (see Figs. 2-4). Similarly to other systems,
famotidine was a more potent H2 antagonist than cimetidine
in HL-60 promyelocytes (see Fig. 2) (18, 20). Additionally, an
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Fig. 3. Inhibition by diphenhydramine, famotidine, or a combination of
both antagonists of histamine-induced rises in [Ca2] in HL-60 promye-
locytes. HL-60 cells were harvested and loaded with fura-2/AM, and the
increases in [Ca2} induced by histamine at various concentrations, in
the absence or presence of antagonists at fixed concentrations (1 00 MM
each), were assessed. Antagonists or solvent (control) were added to
cells 3 mm before histamine. #{149}, Control; U, diphenhydramine; A, famo-
tidine; #{149},diphenhydramine plus famotidine; 0, histamine at the desig-
nated concentrations did not increase [Ca2}. Data shown are the means
± standard deviations of four experiments performed with different
preparations of HL-60 cells.
human myeloid cell lines, i.e., in HL-60 promyelocytes, in U-
937 promonocytes (8, 9, 22), and in the human erythroleukemia
cell lines HEL (23) and K-562 (24). ATP was much more
effective than histamine in activating phosphoinositide degra-
dation and inducing rises in [Ca2]1 in HL-60 promyelocytes
(Table 2; see also Table 1). ATP also effectively increased
[Ca2] in U-937 promonocytes and in HEL cells, whereas in
K-562 cells ATP did not induce rises in [Ca2]1. Unlike ATP,
Discussion
Fig. 4. Inhibition by impromidine and cimetidine of
histamine-induced rises in [Ca21, in HL-60 promyelo-
cytes. HL-60 cells were harvested and loaded with
fura-2/AM, and the increases in [Ca2], induced by
histamine at various concentrations, in the absence
or presence of antagonists at fixed concentrations,
were assessed. Antagonists or solvent (control) were
added to cells 3 mm before histamine. A, #{149}, Control;
U, impromidine (10 nM); A, impromidine (100 nM); Y,
impromidine (1 MM); #{149}, impromidine (10 MM); , im-
promidine (100 MM). B, #{149},Control; U, cimetidine (100
flM); A, cimetidine (300 nM); V, cimetidine (1 MM); #{149},
cimetidine (3 MM). 0, Histamine at the designated
concentrations did not increase [Ca2]. Data shown
are the means ± standard deviations of four experi-
ments performed with different preparations of HL-60
cells.
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Fig. 5. Effect of extracellular Ca2 and of SK&F 96365 on histamine-
induced rises in [Ca21 in HL-60 promyelocytes. HL-60 cells were har-
vested and loaded with fura-2/AM, and the increases in [Ca2] induced
by histamine (100 MM) were assessed. Arrow, addition of histamine.
Three minutes before histamine, various substances were added to cells.
Trace 1, CaCl2 (1 mM); trace 2, CaCI2 (1 mM) plus SK&F 96365 (10 MM);
trace 3, EGTA (1 mM) without added CaCl2. Superimposed original
fluorescence tracings are shown. Similar results were obtained in three
experiments performed with different preparations of HL-60 cells.
TABLE 1
Effects of histamine and ATP on phosphoinositide degradation in
HL-60 promyelocytes
HL-60 cells were cultured for 48 hr in inositol-free RPMI medium supplemented
with myo-[2-’H]inositol, under the conditions described in Experimental Procedures.
Thereafter, labeled cells were washed. HL-60 cells (1 x 106 cells in a volume of
200 MI) were exposed to solvent (control), histamine, or ATP (1 00 MM each) for 30
sec at 37#{176},in the buffer used for the determination of [Ca2J, supplemented with 1
mM cad,. Stopping of the reactions, extraction of inositol phosphates, and
separation of inositol phosphates on Dowex 1 x 8 columns were performed as
described in Experimental Procedures. Data shown are the means ± standard
deviations of assay triplicates. Similar results were obtained in eight experiments
performed with different preparations of HL-60 cells.
Inositol phosphates
Stimulus
lnsP lnsP, lnsP,
c/pm
Solvent (control) 1 042 ± 179 948 ± 49 391 ± 40
Histamine 885 ± 52 925 ± 129 534 ± 32
ATP 1353 ± 36 3021 ± 198 980 ± 73
a lnsP, inositol monophosphate; lnsP,, inositol bisphosphate.
TABLE 2
Effects of ATP and histamine on [Ca2], in various human myeloid
celltypes
HL-60 promyelocytes, U-937 promonocytes, HEL cells, and K-562 cells were
cultured as described in Experimental Procedures. Cells were loaded with fura-2/
AM, and the increases in [Ca’l, induced by AlP and histamine (100 MM each) were
assessed. Basal [Ca’’] in the cell types studied ranged from 1 00 to 230 n. Data
shown are the means ± standard deviations of assay triplicates. Similar results
were obtained in up to nine experiments performed with different preparations of
myeloid cells.
Increase in [Ca2’l
Ceil type
AlP Histamine
flM
HL-60 promyelocytes 1084 ± 1 03 21 3 ± 20
U-937 promonocytes 664 ± 134 0
HEL cells 360 ± 57 0
K-562 cells 0 0
TABLE 3
Effects of histamine, diphenhydramine, and famotidine on fMet-
Leu-Phe-induced rises in [Ca2] in HL-60 cells
HL-60 promyelocytes were cultured for 96 hr with histamine (1 00 MM), to induce
neutrophilic differentiatioi. For comparison, HL-60 promyelocytes were cultured
for 96 hr in the absence of histamine. In addition, cell cultures contained solvent
(control) or histamine receptor antagonists at the indicated concentrations. HL-60
cells were loaded with fura-2/AM, and the increases in [Ca2J induced by fMet-
Leu-Phe (1 MM) were assessed. Basal ICa’i, in the six groups of cells ranged from
100 to 120 n. Data shown are the means ± standard deviations of assay
quadruplicates. Similar results were obtained in three experiments with different
preparations of HL-60 cells.
Increase in [Ca2],
Addition HL-60 HL-60 cells
promyelocytes (histamine)
flM
Solvent (control) 105 ± 8 447 ± 26
Diphenhydramine (1 0 MM) 1 09 ± 12 468 ± 34
Famotidine (1 0 MM) 98 ± 10 1 10 ± 12
H2 agonist (dimaprit) increased [Ca2]1 in HL-60 promyelocytes
to some extent (see Fig. 1), whereas a full H3 agonist and a
partial H, agonist did not. Moreover, famotidine but not di-
phenhydramine antagonized the stimulatory effects of dima-
prit.
The lack of inhibitory effect of pertussis toxin on histamine-
and dimaprit-induced rises in [Ca2J in HL-60 promyelocytes
is also in accordance with the aforementioned assumption,
because H2 receptors couple to the pertussis toxin-insensitive
guanine nucleotide-binding protein G. (see Fig. 1) (6, 18, 25).
Whether H2 receptors additionally couple to one or more of the
recently cloned pertussis toxin-insensitive guanine nucleotide-
binding proteins, e.g., G0 or G,6, to activate phospholipase C
and/or nonselective cation channels, remains to be determined
(26). Interestingly, in dimethyl sulfoxide-differentiated HL-60
cells, H2 receptors mediate increases in [Ca2]1 via pertussis
toxin-insensitive guanine nucleotide-binding proteins as well
(27). Moreover, H2 receptor-mediated rises in [Ca2]1 were
reported for gastric parietal cells (28). Thus, stimulation of
rises in [Ca2’] via H2 receptors is not restricted to HL-60
promyelocytes but may be a more general phenomenon.
Does a H2 receptor subtype mediate the histamine-
induced rises in [Ca24]1 in HL-60 promyelocytes? The
EC5, values for various H2 receptor-mediated responses to
histamine in human neutrophils and HL-60 promyelocytes are
similar, as are the maximally effective concentrations of his-
tamine (see Fig. 1) (1, 3, 14, 22, 27, 29, 30). However, the H2
receptor-mediated increases in [Ca2], in HL-60 promyelocytes
show pharmacological properties that are quite different from
those for inhibition of fMet-Leu-Phe-induced superoxide for-
mation in human neutrophils, for cAMP accumulation in neu-
trophils and HL-60 promyelocytes, and for positive inotropy
and/or chronotropy in the guina pig atrium (standard model
for the characterization of H2 receptors) (1-3, 6, 11, 14, 18, 20).
Impromidine, in addition to being an H2 agonist, is a potent H:3
and weak H, antagonist (6, 18, 19). Interestingly, impromidine
is a partial agonist at H2 receptors in various systems, including
H2 receptors in HL-60 promyelocytes mediating increases in
cAMP (1, 22, 31-33). In contrast to other systems, impromidine
is not an agonist with respect to increases in [Ca2j1 in HL-60
promyelocytes (1, 3, 11, 29). Instead, impromidine reversed
histamine-induced rises in [Ca2] with a potency similar to
that of famotidine (see Fig. 2). Impromidine acted as a mixed
competitive/noncompetitive antagonist and, unlike famotidine,
cimetidine, and diphenhydramine, impromidine abolished the
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rise in [Ca2]1 induced by histamine at 100 tM (see Figs. 2 and
4). It is unlikely that histamine acted via H:3 receptors, because
(R)-cr-methylhistamine, a potent and selective H3 agonist (6,
18, 19), did not increase [Ca2]1. Additionally, dimaprit, which
shows H3 antagonistic effects (19), increased [Ca2]1 in HL-60
promyelocytes (see Fig. 1). Moreover, the stimulatory effects of
dimaprit on [Ca2]1 were inhibited by famotidine. Thus, it
appears that impromidine acted as a dual H,/H2 antagonist to
inhibit histamine-induced rises in [Ca2] in HL-60 promyelo-
cytes (see also below).
Similarly to impromidine, the structurally related guanidine
arpromidine (11) failed to induce rises in [Ca2] in HL-60
promyelocytes, and dimaprit was about 2-fold less potent and
5-fold less effective than histamine in this regard (see Fig. 1).
By comparison, arpromidine is a full agonist with respect to
inhibition of fMet-Leu-Phe-induced superoxide formation in
neutrophils and positive inotropy in the guinea pig atrium (11,
14). Additionally, dimaprit is approximately as potent and as
effective as histamine in increasing cAMP in HL-60 promye-
locytes (2). The failure of H2 agonists to mimic the effects of
histamine is not without precedence in the literature (34).
In human neutrophils and HL-60 promyelocytes, cimetidine
acts as a competitive antagonist to reverse histamine- and
dimaprit-induced cAMP accumulations, and famotidine is a
competitive antagonist of histamine- and arpromidine-induced
inhibition of superoxide formation (1-3, 14, 29). With respect
to histamine-induced increases in [Ca2], in HL-60 promyelo-
cytes, famotidine, cimetidine, and impromidine showed marked
noncompetitive antagonism (see Figs. 3 and 4). It is, however,
unlikely that these substances inhibited rises in [Ca2]1 in HL-
60 promyelocytes in a nonspecific manner, because they did
not inhibit ATP-induced rises in [Ca2]. In other systems,
famotidine shows noncompetitive antagonism versus dimaprit,
but cimetidine does not (18, 20). Moreover, famotidine was
only 3.5-fold more potent than cimetidine in reversing hista-
mine-induced increases in [Ca2]1 in HL-60 promyelocytes, but
in other systems famotidine is at least 10-fold more potent than
cimetidine (see Fig. 2) (18, 20). Taken together, the agonist!
antagonist profiles for H.., receptor-mediated increases in cAMP
and in [Ca2]1 in HL-60 promyelocytes are quite different.
Additionally, there are substantial pharmacological differences
between H2 receptor-mediated increases in [Ca2] in HL-60
promyelocytes and responses in other systems. These data
suggest that histamine mediates increases in cAMP and in
[Ca2], in HL-60 promyelocytes through different receptor sub-
types.
What may be the function of H2 receptor-mediated
increases in [Ca211 in HL-60 promyelocytes? Histamine
induces neutrophilic differentiation of HL-60 promyelocytes,
but it is unknown through which receptor subtype histamine
acts (5). We found that histamine induced expression of formyl
peptide receptors in HL-60 cells (see Table 3). This effect of
histamine was mediated via H2 receptors, inasmuch as it was
abolished by famotidine (see Table 3). These data support the
notion that H2 receptors play a role in neutrophilic differentia-
tion of myeloid progenitor cells, and they are in good agreement
with the clinical finding that long term treatment with H2
antagonists may lead to neutropenia or agranulocytosis (1, 2,
35).
In HL-60 promyelocytes, histamine induces parallel in-
creases in cAMP and in [Ca2]1 (see Figs. 1-5) (1). Ca2’ influx
through nonselective cation channels is required for histamine-
induced differentiation, inasmuch as blockade of these channels
by SK&F 96365 was cytotoxic and prevented differentiation.
H, receptor-mediated rises in [Ca2}1 may potentiate H2 recep-
tor-mediated cAMP accumulation (6). Similarily, H2 receptor-
mediated rises in [Ca2]1 in HL-60 promyelocytes may poten-
tiate H2 receptor-mediated cAMP accumulation. Histamine is
much more effective at inducing rises in cAMP in HL-60
promyelocytes than in human neutrophils (1, 29). The fact that
histamine does not induce rises in [Ca2]1 in human neutrophils
may account, at least in part, for this difference between the
two cell types (1, 4, 29). By analogy to histamine, prostaglandin
E1 is another inducer of differentiation of HL-60 cells (36). The
effectiveness of prostaglandin E, to induce rises in cAMP is
greater in HL-60 promyelocytes than in human neutrophils,
and prostaglandin E1 induces rises in [Ca2]1 in the former cells
but not in the latter (1, 29, 15, 37). Thus, histamine- and
prostaglandin E,-induced rises in [Ca2] in HL-60 promyelo-
cytes may amplify cAMP accumulation, resulting in the induc-
tion of differentiation.
Not only H2 receptors but also ATP receptors mediate func-
tional differentiation of human myeloid cells (see Table 3) (2,
9). Similar to histamine, ATP activates phospholipase C and
induces rises in [Ca2]1 in HL-60 promyelocytes (see Tables 1
and 2) (7, 10, 15). However, stimulation of ATP receptors does
not result in cAMP accumulation (7-9). The Ca2 ionophore
A23187 induces differentiation of HL-60 promyelocytes as well
(38, 39). Thus, an increase in [Ca2]1 may provide a sufficient
signal for the induction of differentiation, independently of
cAMP accumulation. H, receptor-mediated rises in [Ca2] do
not play a role in the induction of differentiation of U-937,
HEL, and K-562 cells, inasmuch as histamine did not increase
[Ca2]1 in these cells (see Table 2). In contrast, ATP increased
[Ca2] in U-937 promonocytes and in HEL cells. Additionally,
ATP was substantially more effective than histamine in acti-
vating phosphoinositide degradation and inducing rises in
[Ca2}1 in HL-60 promyelocytes (see Tables 1 and 2) (7, 10, 15).
These data suggest that ATP and H2 receptor-mediated rises
in [Ca2] play different roles in the regulation of myeloid
differentiation processes.
H, receptors mediate a small portion of histamine-
induced rises in [Ca2]1 in HL-60 promyelocytes. Evidence
in support of the notion that H, receptors mediated a small
part of the histamine-induced rises in [Ca2] in HL-60 pro-
myelocytes comes from the finding that famotidine failed to
reverse completely the stimulation caused by histamine (100
MM) (see Fig. 2). However, famotidine (100 MM) plus diphen-
hydramine (100 MM) abolished the effects of histamine on
[Ca2] (see Fig. 3). With histamine at 100 MM, the H2 antago-
nist-insensitive portion of rises in [Ca2]1 amounted to about
25%, presumably reflecting the H, receptor-mediated responses
(see Fig. 2). The fact that diphenhydramine (100 MM) inhibited
the responses towards histamine (100 sM) to a greater extent
than was expected from the data obtained with cimetidine and
famotidine may be explained by H2 antagonistic properties of
diphenhydramine at the high concentration used (see Fig. 2)
(1, 29). The IC5) for diphenhydramine on rises in [Ca2] in-
duced by histamine (100 tM) in HL-60 promyelocytes is in
agreement with that for dibutyryl-cAMP-differentiated HL-60
cells, and in both cell types diphenhydramine showed marked
noncompetitive antagonism (see Figs. 2 and 3) (4). Moreover,
the data obtained with impromidine support the view that H,
receptors mediated, to a small extent, histamine-induced rises
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in [Ca2]1 in HL-60 promyelocytes (see Figs. 2 and 4) (4, 6, 18).
Apparently, H, receptor-mediated increases in [Ca2}1 per se
were too small to induce differentiation of HL-60 promyelo-
cytes, inasmuch as diphenhydramine did not block stimulation
by histamine of formyl peptide receptor expression (see Table
3).
In conclusion, histamine increases [Ca2]1 in HL-60 promye-
locytes predominantly via H2 receptors and, to a lesser extent,
via H1 receptors. H2 receptor-mediated rises in [Ca2]1 and
cAMP may be mediated through different H2 receptor subtypes.
Activation by histamine of H2 receptors in HL-60 promyelo-
cytes results in activation of nonselective cation channels and
in functional differentiation.
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